Freestone Capital Holdings’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
VCM
Freestone Capital Holdings's TMO Position: Q1 2026 in Review
Freestone Capital Holdings reduced its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, selling an estimated $195K and leaving 29,810 shares worth $14.7M. The position accounts for 0.44% of the portfolio, ranked #38.
Freestone Capital Holdings first reported a position in TMO in Q2 2013 and has held it in 40 quarters since. The position peaked at $17.5M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Freestone Capital Holdings held 29,810 shares of Thermo Fisher Scientific worth $14.7M as of Q1 2026.
- Freestone Capital Holdings sold 359 Thermo Fisher Scientific shares in Q1 2026, an estimated $195K.
- Thermo Fisher Scientific made up 0.44% of Freestone Capital Holdings's portfolio in Q1 2026, its #38 holding.
- Freestone Capital Holdings first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 40 quarters since.
- Freestone Capital Holdings's Thermo Fisher Scientific position peaked at $17.5M in Q4 2025.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.